Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Cancer Center
Tucson, Arizona, United States
- City of Hope National Medical Center
Duarte, California, United States
- University of California, San Diego Medical Center
La Jolla, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Bmt Group of Georgia (northside Hospital)
Atlanta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Kansas Hospital
Kansas City, Kansas, United States
- Louisiana State University Health Sciences Center
Shreveport, Louisiana, United States
- Dfci, Brigham and Womens Hospital
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute/bmt
Detroit, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University, Barnes Jewish Hospital
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Center
Buffalo, New York, United States
- North Shore University Hospital
Lake Success, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- University of North Carolina Hospital at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Jewish Hospital Bmt Program
Cincinnati, Ohio, United States
- University Hospitals of Cleveland/case Western
Cleveland, Ohio, United States
- Ohio State/arthur G. James Cancer Hospital
Columbus, Ohio, United States
- University of Oklahoma Medical Center
Oklahoma City, Oklahoma, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Penn State College of Medicine, the Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Sarah Cannon Blood & Marrow Transplant Program
Nashville, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Texas/md Anderson Crc
Houston, Texas, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- West Virginia University Hospital
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2015
- Primary completion
- 7 Jun 2019
- Completion
- 7 Jun 2019
- Last update posted
- 11 May 2020
- Registered enrollment
- 273
- Registry id
- NCT02322320
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.